DEFINING THE SMALLEST ANALYTE CONCENTRATION AN IMMUNOASSAY CAN MEASURE

Citation
En. Brown et al., DEFINING THE SMALLEST ANALYTE CONCENTRATION AN IMMUNOASSAY CAN MEASURE, Clinical chemistry, 42(6), 1996, pp. 893-903
Citations number
50
Categorie Soggetti
Chemistry Medicinal
Journal title
ISSN journal
00099147
Volume
42
Issue
6
Year of publication
1996
Part
1
Pages
893 - 903
Database
ISI
SICI code
0009-9147(1996)42:6<893:DTSACA>2.0.ZU;2-B
Abstract
An immunoassay's minimal detectable concentration ((MDC), the smallest analyte concentration the assay can reliably measure, is one of its m ost important properties. Bayes' theorem is used to unify the five cur rent mathematical MDC definitions. The unified definition has signific ant implications for defining positive results for screening and diagn ostic tests, setting criteria for immunoassay quality control and opti mal design, reliably measuring biological substances at low concentrat ions, and, in general, measuring small analyte concentrations with cal ibrated analytic methods, As an illustration, we apply the unified def inition to the microparticle capture enzyme immunoassay for prostate-s pecific antigen (PSA) developed for the Abbott IMxm(TM) automated immu noassay system. The MDC of this assay as estimated by our unifying app roach is shown to be 4.1-7.1 times greater than currently reported, As a consequence, the ability of the assay to measure reliably small con centrations of PSA to detect early recurrences of prostate cancer is p robably overstated.